IFIBYNE   05513
INSTITUTO DE FISIOLOGIA, BIOLOGIA MOLECULAR Y NEUROCIENCIAS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
DNA damage and chromatin structure control alternative splicing through its kinetic coupling with transcription.
Autor/es:
MUÑOZ M; SCHOR IE; ALLO M; RASCOVAN N; PEREZ SANTANGELO S; PETRILLO E; FEDEDA JP; DE LA MATA M; KORNBLIHTT AR
Lugar:
Lisboa, Portugal
Reunión:
Jornada; Reunión de HHMI International Research Scholars; 2008
Institución organizadora:
Howard Hughes Medical Institute (HHMI)
Resumen:
<!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:variable;
mso-font-signature:-1610611985 1107304683 0 0 159 0;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-pitch:variable;
mso-font-signature:-1610611985 1073741899 0 0 159 0;}
@font-face
{font-family:Palatino;
mso-font-alt:"Book Antiqua";
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:50331648 0 0 0 1 0;}
@font-face
{font-family:Verdana;
panose-1:2 11 6 4 3 5 4 4 2 4;
mso-font-charset:0;
mso-generic-font-family:swiss;
mso-font-pitch:variable;
mso-font-signature:-1593833729 1073750107 16 0 415 0;}
@font-face
{font-family:Times;
panose-1:2 2 6 3 5 4 5 2 3 4;
mso-font-charset:0;
mso-generic-font-family:auto;
mso-font-pitch:variable;
mso-font-signature:50331648 0 0 0 1 0;}
@font-face
{font-family:AdvMinionNormal_Rm;
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:auto;
mso-font-signature:3 0 0 0 1 0;}
@font-face
{font-family:TimesNewRomanPS;
panose-1:0 0 0 0 0 0 0 0 0 0;
mso-font-charset:0;
mso-generic-font-family:roman;
mso-font-format:other;
mso-font-pitch:auto;
mso-font-signature:3 0 0 0 1 0;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{mso-style-unhide:no;
mso-style-qformat:yes;
mso-style-parent:"";
margin:0cm;
margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-size:12.0pt;
font-family:"Times New Roman","serif";
mso-fareast-font-family:"Times New Roman";
mso-ansi-language:EN-US;
mso-fareast-language:EN-US;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
{mso-style-unhide:no;
mso-style-link:"Texto independiente 2 Car";
margin:0cm;
margin-bottom:.0001pt;
text-align:center;
line-height:200%;
mso-pagination:widow-orphan;
font-size:16.0pt;
mso-bidi-font-size:10.0pt;
font-family:Palatino;
mso-fareast-font-family:Times;
mso-hansi-font-family:Palatino;
mso-bidi-font-family:"Times New Roman";
mso-ansi-language:EN-US;
mso-fareast-language:ES-TRAD;
font-weight:bold;
mso-bidi-font-weight:normal;}
span.articletext1
{mso-style-name:articletext1;
mso-style-unhide:no;
mso-ansi-font-size:10.0pt;
mso-bidi-font-size:10.0pt;
font-family:"Verdana","sans-serif";
mso-ascii-font-family:Verdana;
mso-hansi-font-family:Verdana;
color:black;}
span.Textoindependiente2Car
{mso-style-name:"Texto independiente 2 Car";
mso-style-unhide:no;
mso-style-locked:yes;
mso-style-link:"Texto independiente 2";
mso-ansi-font-size:16.0pt;
font-family:Palatino;
mso-ascii-font-family:Palatino;
mso-fareast-font-family:Times;
mso-hansi-font-family:Palatino;
mso-ansi-language:EN-US;
mso-fareast-language:ES-TRAD;
font-weight:bold;
mso-bidi-font-weight:normal;}
.MsoChpDefault
{mso-style-type:export-only;
mso-default-props:yes;
font-size:10.0pt;
mso-ansi-font-size:10.0pt;
mso-bidi-font-size:10.0pt;}
@page Section1
{size:595.2pt 841.6pt;
margin:72.0pt 90.0pt 72.0pt 90.0pt;
mso-header-margin:36.0pt;
mso-footer-margin:36.0pt;
mso-paper-source:0;}
div.Section1
{page:Section1;}
-->
Alternative splicing (AS) affects the expression of 65% of human
genes, generates high protein diversity and is implicated in
human disease. The rate of
transcription elongation determines the outcome of two competing
splicing reactions that occur co-transcriptionally. Rapid
transcription favors exon skipping, whereas slower transcriptionfavors exon inclusion. We present here evidence for three different
mechanisms that control AS through the kinetic coupling.
1. UV radiation affects AS of many genes, including the
upregulation of the pro-apoptotic isoform of Bcl-x, an expected physiological
response to DNA damage. The UV effect does not require p53, is not caused by
the damage of the DNA template in cis
and only affects co-transcriptional splicing. UV light causes
hyperphosphorylation of the carboxy terminal domain of RNA polymerase II, which
is responsible for the alteration in AS through the inhibition of transcriptional
elongation. Pol II mutants engineered to mimic the hyperphosphorylated state
duplicate the effects of UV light on AS.
2. The chromatin context
affects Pol II elongation rates and in turn, AS. We report here the mechanism
by which membrane
depolarization in nerve cells affects AS of the NCAM pre-mRNA. Depolarization
promotes local heterochromatinization around the alternative exon on the NCAM
gene, which creates roadblocks to Pol II elongation.
3. In search for new tools
to control AS at the chromatin level, we found that small interfering RNAs
(siRNAs) targeted to the intron located downstream of an alternative exon
affect AS through a mechanism known as transcriptional gene silencing (TGS).
The intronic siRNAs trigger heterochromatinization on DNA target sequences by causing histone H3 Lys9
dimethylation. The effects of intronic siRNAs on AS are not caused by
conventional post-transcriptional gene silencing (PTGS), are abolished by
inhibitors of histone deacetylation and methylation and depend on the presence
of the protein Ago2, known to be necessary for TGS.